Replies to post #117984 on Biotech Values

[mcbio]

GILD's decision not to pursue nukes in HCV earlier was as big a gaffe as Roche not licensing the pro-drugs to PSI-7851 from VRUS.

Pretty much. It's even more of an amazing gaffe when you consider the success they had in HIV with nukes.